These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
648 related items for PubMed ID: 17349210
1. TNF-alpha induces transient resistance to Fas-induced apoptosis in eosinophilic acute myeloid leukemia cells. Qin Y, Auh S, Blokh L, Long C, Gagnon I, Hamann KJ. Cell Mol Immunol; 2007 Feb; 4(1):43-52. PubMed ID: 17349210 [Abstract] [Full Text] [Related]
2. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis. Huerta-Yepez S, Vega M, Garban H, Bonavida B. Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892 [Abstract] [Full Text] [Related]
3. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF. Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450 [Abstract] [Full Text] [Related]
4. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation. Tse AK, Wan CK, Shen XL, Yang M, Fong WF. Biochem Pharmacol; 2005 Nov 15; 70(10):1443-57. PubMed ID: 16181613 [Abstract] [Full Text] [Related]
5. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV. Oncogene; 2001 Nov 29; 20(55):7965-75. PubMed ID: 11753679 [Abstract] [Full Text] [Related]
11. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation. Qin Y, Camoretti-Mercado B, Blokh L, Long CG, Ko FD, Hamann KJ. J Immunol; 2002 Oct 01; 169(7):3536-44. PubMed ID: 12244143 [Abstract] [Full Text] [Related]
13. Inhibition of nuclear factor-kappaB activation confers sensitivity to tumor necrosis factor-alpha by impairment of cell cycle progression in human glioma cells. Otsuka G, Nagaya T, Saito K, Mizuno M, Yoshida J, Seo H. Cancer Res; 1999 Sep 01; 59(17):4446-52. PubMed ID: 10485496 [Abstract] [Full Text] [Related]